An error has occurred while submitting. Please try again.
Your form was submitted successfully, and a 3M rep will reach out to you.
Research has shown that patients with diabetes have up to a 25% lifetime risk of diabetic foot ulceration (DFU), one of the most frequently recognized complications of diabetes.¹ DFUs are the leading non-traumatic cause of lower extremity foot amputations worldwide.²
Every wound is unique and may require a cascading approach to treatment. It has been demonstrated that early initiation* of our Negative Pressure Wound Therapy can reduce time to significant closure by up to 50% for acute wounds and 67% for chronic wounds.** We also offer a full suite of Advanced Wound Dressings and Skin Integrity Solutions to help your patients complete their journey to healing.
*Defined as treatment within the first 7 days for acute wound and 30 days for chronic wounds from the first wound treatment date.
** Based on a retrospective analysis conducted on a national insurance provider’s medical claims data, which examined 6,181 acute and 1,480 chronic wound patients that received NPWT from January 1, 2009 to June 30, 2011.
An estimated $9-13 billion is spent to treat DFUs in the United States healthcare system annually¹.
People with diabetes have a 15-25% lifetime risk of developing DFUs³.
Patients with a DFU have a 2.5x higher risk of death at five years than patients without a DFU⁴.
NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for these products and therapies, some of which may be Rx only. Please consult a clinician and product instruction for use prior to application.
1. Bradford Rice J, Desai U, et al. Burden of Diabetic Foot Ulcers for Medicare and Private Insurers. Diabetes Care 2014; 37:651–658.
2. Hingorani, A., LaMuraglia, G. M., Henke, P., Meissner, M. H., Loretz, L., Zinszer, K. M., ... & Mills Sr, J. L. (2016). The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. Journal of vascular surgery, 63(2), 3S-21S.
3. Singh N, Armstrong DA, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-28.
4. Armstrong D, Boulton M.D., Bus S. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med, 2017; 376;24.